問卷

TPIDB > Principal Investigator

Principal Investigator


CHANGHUA CHRISTIAN HOSPITAL (在職)

Division of Hematology & Oncology

Division of Radiation Therapy

更新時間:2023-09-19

林敬業
  • Principal Investigator
  • Clinical Trial Experience (year)

篩選

List

72Cases

2019-01-11 - 2024-12-31

Phase II

Completed
  • Condition/Disease

  • Test Drug

Participate Sites
7Sites

Recruiting6Sites

Terminated1Sites

2020-11-18 - 2024-12-31

Phase II

Completed
An Exploratory, Randomised, Double-blind, Parallel-Group, Placebo-Controlled Phase IIa Study to Assess the Analgesic Activity of PAX-1 in Patients with Persistent Cancer Pain.
  • Condition/Disease

    Persistent Cancer Pain

  • Test Drug

    PAX-1

Participate Sites
7Sites

Recruiting2Sites

Terminated5Sites

2018-06-26 - 2030-12-31

Phase II

Active
  • Condition/Disease

  • Test Drug

Participate Sites
8Sites

Recruiting7Sites

2013-08-12 - 2026-03-17

Phase III

Active
  • Condition/Disease

  • Test Drug

Participate Sites
5Sites

Recruiting5Sites

2017-08-10 - 2021-06-30

Phase III

Completed
  • Condition/Disease

  • Test Drug

Participate Sites
14Sites

Terminated12Sites

2017-07-18 - 2026-06-30

Phase III

Active
  • Condition/Disease

  • Test Drug

Participate Sites
8Sites

Recruiting6Sites

2018-09-01 - 2026-10-02

Phase III

Active
  • Condition/Disease

  • Test Drug

Participate Sites
6Sites

Not yet recruiting1Sites

Recruiting4Sites

2023-03-01 - 2028-10-16

Phase III

Active
  • Condition/Disease

  • Test Drug

Participate Sites
9Sites

Not yet recruiting7Sites

Recruiting1Sites

2019-10-30 - 2026-11-30

Phase III

Completed
  • Condition/Disease

  • Test Drug

Participate Sites
5Sites

Recruiting5Sites

2014-01-01 - 2021-12-31

Phase III

Completed
  • Condition/Disease

  • Test Drug

Participate Sites
9Sites

Terminated9Sites